We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+4.31%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$16.4B
AUM Growth
+$49.9M
(+0.3%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-2.16%
Top 10 Holdings %
Top 10 Hldgs %
43.8%
Holding
1,532
New
77
Increased
144
Reduced
521
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coty
COTY
|
+$139M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$38M |
| 3 |
GCP
GCP Applied Technologies Inc.
GCP
|
+$34.7M |
| 4 |
Sonida Senior Living
SNDA
|
+$25.5M |
| 5 |
Theravance Biopharma
TBPH
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$68M |
| 2 |
ConocoPhillips
COP
|
+$44.3M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$35.7M |
| 4 |
Zimmer Biomet
ZBH
|
+$33.7M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 37.47% |
| 2 | Healthcare | 12.64% |
| 3 | Industrials | 9.32% |
| 4 | Technology | 8.7% |
| 5 | Consumer Staples | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BFS
301
Saul Centers
BFS
$875M
| $2.54M | 0.02% |
38,067
| – | – |
|
302
Qualcomm
QCOM
$176B
| $2.49M | 0.02% |
38,245
-36,240
| -49% | -$2.43M |
|
303
Prothena Corp
PRTA
$458M
| $2.46M | 0.02% |
+50,000
| New | +$2.76M |
|
304
Blackstone
BX
$104B
| $2.46M | 0.01% |
90,830
-19,825
| -18% | -$514K |
|
305
Atlanta Braves Holdings Series B
BATRK
$3.23B
| $2.43M | 0.01% |
118,131
-1,344
| -1% | -$25K |
|
306
Equity Residential
EQR
$25.4B
| $2.41M | 0.01% |
37,448
| – | – |
|
307
Motorola Solutions
MSI
$69.4B
| $2.37M | 0.01% |
28,631
-19
| -0.1% | -$1.49K |
|
308
SLM Corp
SLM
$4.58B
| $2.37M | 0.01% |
215,103
| – | – |
|
|
BRT
309
BRT Apartments
BRT
$282M
| $2.35M | 0.01% |
287,237
+2,100
| +0.7% | +$16.6K |
|
310
Pinnacle West Capital
PNW
$12.9B
| $2.33M | 0.01% |
29,895
-1,350
| -4% | -$101K |
|
|
BSTC
311
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $2.29M | 0.01% |
41,180
-2,200
| -5% | -$106K |
|
312
Korea Electric Power
KEP
$15.5B
| $2.26M | 0.01% |
122,379
+66,141
| +118% | +$1.38M |
|
313
Mercury Insurance
MCY
$5.94B
| $2.24M | 0.01% |
37,242
-400
| -1% | -$22.7K |
|
|
FDML
314
DELISTED
Federal-Mogul Holdings Corporation
FDML
| $2.23M | 0.01% |
215,948
-50,581
| -19% | -$491K |
|
315
Lamar Advertising Co
LAMR
$16.2B
| $2.21M | 0.01% |
32,886
+13,792
| +72% | +$894K |
|
316
Leggett & Platt
LEG
$1.52B
| $2.19M | 0.01% |
44,769
-1,060
| -2% | -$50.4K |
|
317
Allstate
ALL
$66.9B
| $2.18M | 0.01% |
29,467
| – | – |
|
318
Vulcan Materials
VMC
$36.3B
| $2.18M | 0.01% |
17,400
-100
| -0.6% | -$12.1K |
|
|
RDS.A
319
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.17M | 0.01% |
39,951
-2,942
| -7% | -$152K |
|
|
WPZ
320
DELISTED
Williams Partners L.P.
WPZ
| $2.15M | 0.01% |
56,508
-7,563
| -12% | -$272K |
|
321
Texas Instruments
TXN
$255B
| $2.11M | 0.01% |
28,902
-678
| -2% | -$48.4K |
|
322
Clorox
CLX
$11.6B
| $2.09M | 0.01% |
17,407
+100
| +0.6% | +$11.8K |
|
|
HES
323
DELISTED
Hess
HES
| $2.08M | 0.01% |
33,328
| – | – |
|
|
CTWS
324
DELISTED
Connecticut Water Service Inc
CTWS
| $2.07M | 0.01% |
37,121
-925
| -2% | -$49.2K |
|
325
Commercial Vehicle Group
CVGI
$157M
| $2.04M | 0.01% |
368,642
-127,973
| -26% | -$679K |
|
Similar funds
SAM
First Manhattan's Q4 2016 Portfolio in Review
As of Q4 2016, First Manhattan held 1,532 positions worth $16.4B, up 0.3% from $16.4B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
First Manhattan's Q4 2016 filing shows 77 new, 144 increased, 521 reduced and 96 closed positions. Its largest new stake was Coty: 6,723,666 shares worth $123M. The largest sale was Allergan plc, an estimated $68M.
By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q4 2016 buy was Coty: 6,723,666 shares worth $123M.
- First Manhattan added most to Teva Pharmaceuticals in Q4 2016, an estimated $38M increase.
- First Manhattan's biggest Q4 2016 reduction was Allergan plc, cutting an estimated $68M.
- First Manhattan fully exited Starz - Series A in Q4 2016, selling an estimated $2.9M.
- First Manhattan's ten largest holdings make up 44% of its $16.4B portfolio in Q4 2016.
- First Manhattan opened 77 new positions and closed 96 in Q4 2016.
- First Manhattan's portfolio value rose 0.3% quarter-over-quarter to $16.4B.
Based on First Manhattan's 13F filing for Q4 2016, filed 25 Jan 2017.